IP Library Granted Patent US 7,338,471
Granted Patent B2
US 7,338,471 · App. 10/977,594 · Granted Mar 4, 2008

Apparatus and methods for treating tissue using passive injection systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,338,471
App. No.
10/977,594
Granted
Mar 4, 2008
Kind
B2
Abstract

Methods and apparatus are provided for treating damaged tissue using apparatus that atraumatically delivers a bioactive agent within the tissue, wherein the apparatus provides a column of stem cells may be advanced simultaneously with a needle during needle insertion, and then held stationary or injected at low pressure while retracting the needle. Alternatively, the needle may employ electromotive forces, or to change a dimension of the needle, to expel the bioactive agent into the needle track.

Claims (29)

1. Apparatus for atraumatically dispensing a bioactive agent within a needle track to promote regeneration of a damaged region of tissue or nerve, the apparatus comprising:

a syringe having a body, a barrel, an internal lumen extending therebetween and a piston slidably disposed in the lumen;

a tube having a proximal end adapted to be coupled to the barrel of the syringe and a distal end defining an injection needle;

a housing configured to accept the syringe and the tube; and

an actuator disposed within the housing and configured to engage the tube and the syringe,

wherein the actuator is moves the body, piston and tube in unison in a distal direction during a first range of motion, and holds the piston stationary while retracting the body and tube during a second range of motion.

2. The apparatus of claim 1 wherein the actuator comprises a trigger pivotally mounted to the housing.

3. The apparatus of claim 1 wherein the actuator comprises:

a clamp adapted to engage the body of the piston;

a gear train coupled to the trigger; and

a linkage having a first end coupled to the gear train and a second end coupled to the clamp.

4. The apparatus of claim 3 wherein the actuator further comprises a rail having a first end coupled to the piston and a second end selectively coupled to the linkage.

5. The apparatus of claim 2 wherein the trigger is spring-biased.

6. The apparatus of claim 1 wherein the injection needle comprises an array of needles that flare outward when the injection needle is actuated during the first range of motion.

7. The apparatus of claim 1 wherein the tube is removably coupled to the barrel of the syringe.

8. The apparatus of claim 1 , wherein the injection needle comprises an array of needles configured to simultaneously deliver bioactive agent at various depths within the damaged region.

9. The apparatus of claim 1 , wherein the injection needle comprises an array of needles configured to simultaneously deliver bioactive agent at multiple locations along a length of the damaged region.

10. The apparatus of claim 1 , further comprising a grid having an array of apertures to guide the injection needle to predetermined locations along a length of the damaged region.

11. The apparatus of claim 2 , wherein a half-way depression of the trigger causes the actuator to move the body, piston and tube during the first range of motion, and wherein a successive half-way depression of the trigger causes the actuator to hold the piston stationary while retracting the body and tube during the second range of motion.

12. The apparatus of claim 6 , wherein the needles flare outwards by curving away from one another.

13. The apparatus of claim 6 , wherein the array of needles comprises three needles.

14. The apparatus of claim 1 , wherein the retracting of the body and tube during the second range of motion causes the injection needle to retract, and further causes a fluid contained in the syringe to be dispensed into a track formed by the injection needle.

15. The apparatus of claim 14 , wherein the retracting of the body and tube during the second range of motion further causes the fluid to remain essentially stationary during the retracting, and further causes the fluid to be dispensed essentially free of turbulent motion.

16. The apparatus of claim 14 , wherein the fluid is a bioactive agent.

17. The apparatus of claim 16 , wherein the bioactive agent comprises stem cells.

18. The apparatus of claim 16 , wherein the bioactive agent is dispersed in a solution comprising one or more of a nutrient, a drug, and a hormone.

19. The apparatus of claim 1 , wherein the injection needle is configured for injection into the spinal cord.

20. The apparatus of claim 1 , wherein the injection needle is configured for injection into heart tissue.

21. The apparatus of claim 1 , wherein the injection needle is configured for injection into brain tissue.

Assignments (4)
SECURITY INTEREST Recorded Feb 28, 2024
From: COOK MEDICAL TECHNOLOGIES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 066700/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2014
From: NEXEON MEDSYSTEMS, INC.
To: COOK MEDICAL TECHNOLOGIES LLC
Reel/Frame 034174/0613 →
MERGER Recorded Jan 23, 2009
From: PARAGON INTELLECTUAL PROPERTIES, LLC
To: NEXEON MEDSYSTEMS, INC.
Reel/Frame 022137/0876 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2005
From: BATES, MARK C.
To: PARAGON INTELLECTUAL PROPERTIES, LLC
Reel/Frame 016319/0815 →